CHM 4.17% 1.2¢ chimeric therapeutics limited

Interesting line in todays ANN by CHM, Chamelean will contend...

  1. 2,627 Posts.
    lightbulb Created with Sketch. 6
    Interesting line in todays ANN by CHM, Chamelean will contend that the accounting for profits must have regard to the capital gain achieved by MMX from the use of the funds.

    They highlight the judges key words 'profit OR benefit'.

    So whilst MMX stated today they had no profit from the project, they did not rule out MMX derived no benefit from the project since purchase.

    Therefore CHM's demand is for 24% of the capital Gains made by MMX since 2004.
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.